These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3731685)

  • 1. Absorption and disposition of two combination formulations of hydrochlorothiazide and triamterene: influence of age and renal function.
    Williams RL; Thornhill MD; Upton RA; Blume C; Clark TS; Lin E; Benet LZ
    Clin Pharmacol Ther; 1986 Aug; 40(2):226-32. PubMed ID: 3731685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new antihypertensive agent: Maxzide (75 mg triamterene/50 mg hydrochlorothiazide).
    Blume CD; Williams RL
    Am J Med; 1984 Nov; 77(5A):52-8. PubMed ID: 6388327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the anti-hypertensive effectiveness of two triameterene/hydrochlorothiazide combinations: Maxzide versus Dyazide.
    Casner PR; Dillon KR
    J Clin Pharmacol; 1990 Aug; 30(8):715-9. PubMed ID: 2401750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and bioequivalence of a brand-name and a generic triamterene-hydrochlorothiazide combination product.
    Sharoky M; Perkal M; Tabatznik B; Cane RC; Costello K; Goodwin P
    Clin Pharm; 1989 Jul; 8(7):496-500. PubMed ID: 2752698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of a significant pharmacokinetic interaction between hydrochlorothiazide and triamterene when coadministered.
    Upton RA; Williams RL; Lin ET; Gee WL; Blume CD; Benet LZ
    J Pharmacokinet Biopharm; 1984 Dec; 12(6):575-86. PubMed ID: 6533293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with a new combination formulation of triamterene and hydrochlorothiazide (Maxzide) in patients with mild to moderate hypertension.
    Williams RL; Clark T; Blume CD
    Am J Med; 1984 Nov; 77(5A):62-6. PubMed ID: 6388328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maxzide or Dyazide: a cautionary note.
    Kaplan NM
    Ann Intern Med; 1985 May; 102(5):717. PubMed ID: 3838634
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioequivalence study of a new tablet formulation of triamterene and hydrochlorothiazide.
    Blume CD; Williams RL; Upton RA; Lin ET; Benet LZ
    Am J Med; 1984 Nov; 77(5A):59-61. PubMed ID: 6496560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral triamterene disposition.
    Sörgel F; Hasegawa J; Lin ET; Williams RL
    Clin Pharmacol Ther; 1985 Sep; 38(3):306-12. PubMed ID: 4028626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the bioavailability of hydrochlorothiazide and triamterene from commercial drugs (author's transl)].
    Knauf H; Möhrke W; Mutschler E; Völger KD
    Arzneimittelforschung; 1980; 30(6):1001-4. PubMed ID: 7191258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triamterene nephrolithiasis complicating dyazide therapy.
    Patel KM
    J Urol; 1981 Aug; 126(2):230. PubMed ID: 7265370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of a hydrochlorothiazide plus triamterene combination (Dyazide) and atenolol in the treatment of patients with mild hypertension: a multicentre study in general practice.
    Philip IG; Qureshi SM; Richards HH; Sharma SK; Wright FG; Young PH; Rowley-Jones D
    Br J Clin Pract; 1987 Oct; 41(10):947-53. PubMed ID: 3333144
    [No Abstract]   [Full Text] [Related]  

  • 13. Absorption and disposition of a new low-dose combination formulation of hydrochlorothiazide and triamterene.
    Williams RL; Lin ET; Liang-Gee W; Blume CD; Benet LZ
    Biopharm Drug Dispos; 1990 Apr; 11(3):233-43. PubMed ID: 2328310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive therapy with triamterene-hydrochlorothiazide vs amiloride-hydrochlorothiazide. Comparison of effects on urinary prostaglandin E2 excretion.
    Zawada ET
    Arch Intern Med; 1986 Jul; 146(7):1312-4. PubMed ID: 3521523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single-blind, randomized, cross-over study of angiotensin-converting enzyme inhibitor and triamterene and hydrochlorothiazide in the treatment of mild to moderate hypertension in the elderly.
    Woo J; Woo KS; Kin T; Vallance-Owen J
    Arch Intern Med; 1987 Aug; 147(8):1386-9. PubMed ID: 2820329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of a fixed combination with propranolol, hydrochlorothiazide and triamterene.
    Felder K; Geissler HE; Hiemstra S; Mutschler E; Schäfer M; Ziegler E
    Arzneimittelforschung; 1979; 29(11):1746-52. PubMed ID: 543886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relation between the hypotensive effect of triampur and its pharmacokinetics in patients with hypertension].
    Kuznetsov GP; Lebedev PA
    Kardiologiia; 1986 Mar; 26(3):49-52. PubMed ID: 3712933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Triamterene in the treatment of hypertension with hydrochlorothiazide and propranolol (author's transl)].
    Düsing R; Kramer HJ
    Dtsch Med Wochenschr; 1977 Oct; 102(43):1541-6. PubMed ID: 913294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PACT study: post-marketing surveillance in 47,465 patients treated with Maxzide (triamterene/hydrochlorothiazide). An interim report.
    Hollenberg NK; Bannon JA
    Am J Med; 1986 Apr; 80(4A):30-6. PubMed ID: 3518430
    [No Abstract]   [Full Text] [Related]  

  • 20. Preliminary observations on dissolution and bioavailability of triamterene-hydrochlorothiazide combination products.
    Shah VP; Walker MA; Prasad VK; Lin J; Knapp G; Cabana BE
    Biopharm Drug Dispos; 1984; 5(1):11-9. PubMed ID: 6704502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.